Early Lapatinib-Induced Skin Rash Predicts Better Survival With

$ 19.50

4.6
(718)
In stock
Description

Early development of skin rash following lapatinib and trastuzumab therapy is associated with improved survival.

Lapatinib (Tyverb)

HER-2 directed therapy in advanced breast cancer

PDF] Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO

Targeted therapeutic options and future perspectives for HER2

Efficacy and Tolerability of Lapatinib in the Management of Breast

Effects of lapatinib monotherapy: results of a randomised phase II

Interdisciplinary management of EGFR-inhibitor-induced skin

Interdisciplinary management of EGFR-inhibitor-induced skin

PDF) Lapatinib and lapatinib plus trastuzumab therapy versus

Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal

Efficacy and Tolerability of Lapatinib in the Management of Breast